Denali Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
DNLI on Nasdaq
Location
161 Oyster Point Blvd., South San Francisco, California

Insiders trading volume in the past year

Denali Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Nelsen Director $178 M Jun 2, 2021
Ryan J. Watts President and CEO, Director $50 M -$776 K -1.53% Mar 29, 2024
Marc Tessier-Lavigne Director $43.2 M May 31, 2024
E. Krognes Director $19.9 M -$2.72 M -12% Jun 13, 2024
Alexander O. Schuth COFO and Secretary $12.6 M -$1.43 M -10.2% Feb 13, 2024
Jay T. Flatley Director $7.07 M May 31, 2024
Carole Ho Chief Medical Officer $3 M -$605 K -16.8% Feb 13, 2024
Vicki L. Sato Director $2.73 M -$462 K -14.5% Jul 1, 2024
David Schenkein Director $973 K May 31, 2024
Douglas G. Cole Director $489 K Jun 1, 2023
Peter S. Klein Director $438 K May 31, 2024
Jennifer E. Cook Director $435 K -$31.7 K -6.78% Jun 6, 2024
Nancy Thornberry Director $381 K May 31, 2024
Erik Harris Director $348 K May 31, 2024

Recent Insider Transactions by Companies or Individuals for Denali Therapeutics Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership